Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 03 04:00PM ET
3.14
Dollar change
+0.17
Percentage change
5.72
%
Index- P/E- EPS (ttm)-1.47 Insider Own45.61% Shs Outstand27.29M Perf Week27.13%
Market Cap85.69M Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float14.84M Perf Month13.77%
Income-39.90M PEG- EPS next Q-0.27 Inst Own19.08% Short Float0.44% Perf Quarter-18.86%
Sales75.33M P/S1.14 EPS this Y39.41% Inst Trans- Short Ratio0.89 Perf Half Y17.60%
Book/sh-0.04 P/B- EPS next Y32.45% ROA-29.28% Short Interest0.06M Perf Year-15.59%
Cash/sh0.53 P/C5.91 EPS next 5Y- ROE-217.59% 52W Range2.15 - 4.64 Perf YTD-20.30%
Dividend Est.- P/FCF- EPS past 5Y21.65% ROI-105.24% 52W High-32.33% Beta0.49
Dividend TTM- Quick Ratio1.53 Sales past 5Y34.90% Gross Margin54.94% 52W Low46.05% ATR (14)0.19
Dividend Ex-Date- Current Ratio1.69 EPS Y/Y TTM47.07% Oper. Margin-33.83% RSI (14)71.54 Volatility6.41% 6.43%
Employees300 Debt/Eq- Sales Y/Y TTM- Profit Margin-52.97% Recom1.00 Target Price7.25
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q37.62% Payout- Rel Volume2.33 Prev Close2.97
Sales Surprise9.42% EPS Surprise-3.61% Sales Q/Q34.93% EarningsMay 08 AMC Avg Volume72.73K Price3.14
SMA2027.84% SMA5012.21% SMA200-0.86% Trades Volume169,443 Change5.72%
Date Action Analyst Rating Change Price Target Change
May-31-23Initiated TD Cowen Outperform $7
Jul-18-22Resumed Oppenheimer Outperform $18
May-01-24 01:53PM
07:45AM
Mar-28-24 01:30PM
Mar-12-24 04:00PM
Mar-07-24 10:42AM
04:00PM Loading…
Mar-06-24 04:00PM
Feb-21-24 05:00PM
Feb-16-24 08:45AM
Jan-08-24 04:00PM
Dec-18-23 01:00AM
Nov-27-23 01:00AM
Nov-14-23 04:00PM
Nov-13-23 04:00PM
Nov-08-23 04:00PM
Nov-06-23 01:00AM
04:00PM Loading…
Oct-25-23 04:00PM
Oct-20-23 04:00PM
Oct-09-23 04:00PM
Oct-02-23 04:04PM
Sep-26-23 04:46PM
Aug-23-23 04:00PM
Aug-10-23 04:00PM
Aug-09-23 04:00PM
Aug-03-23 07:25PM
Jun-30-23 04:00PM
Jun-05-23 05:30PM
May-25-23 04:30PM
May-23-23 04:00PM
May-15-23 04:00PM
May-01-23 04:00PM
04:00PM Loading…
Apr-25-23 04:00PM
Apr-19-23 04:00PM
Apr-07-23 04:30PM
Mar-13-23 02:00AM
Mar-08-23 05:00PM
04:00PM
Mar-06-23 05:34PM
Mar-03-23 04:30PM
Feb-28-23 04:30PM
Feb-22-23 04:30PM
Feb-21-23 04:30PM
Feb-15-23 04:30PM
Feb-13-23 04:00PM
Feb-03-23 08:00AM
Feb-01-23 04:00PM
Jan-20-23 01:00AM
Jan-09-23 04:00PM
Dec-19-22 05:00PM
Nov-29-22 04:06PM
Nov-04-22 01:33PM
Oct-27-22 04:00PM
Aug-25-22 04:00PM
Aug-19-22 04:00PM
Aug-09-22 10:09AM
Aug-02-22 04:30PM
04:00PM
May-25-22 04:00PM
May-19-22 04:00PM
Apr-27-22 04:00PM
Apr-25-22 04:00PM
Mar-30-22 04:30PM
Mar-02-22 04:00PM
Feb-17-22 04:00PM
Feb-09-22 04:00PM
Dec-10-21 06:01PM
Nov-22-21 05:00PM
Nov-15-21 05:00PM
Nov-09-21 03:38PM
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.